👉 Biotech startups are built on progress. New data, stronger validation, deeper insight into the biology. Every week brings movement in the lab, and every milestone feels like a step forward. Yet many founders experience a strange disconnect. Science advances, but funding momentum does not. The pipeline improves, but strategic leverage does not expand. The team works intensely, yet the company does not feel closer to its next inflection point. 👉 At some stage, the uncomfort

In biotech, science alone isn’t enough to win. You can have the most groundbreaking therapy in the pipeline, but if you lose public...

👉 Scaling up is the critical inflection point for any biotech company. While achieving early success as a startup is a significant...

Biotech founders are doers by necessity. The clock is ticking, the science is demanding, and the runway is already shrinking. Pitch...

In Biotech, Certainty Is a Mirage Scientific training primes founders to seek certainty . Hypothesize, experiment, validate — it’s a...